Who
Alon Ben-Noon
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, NeuroSense Therapeutics.
In numbers
- Trades disclosed
- 2
- Buys
- 1
- Sells
- 0
- Bought
- $400K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jun 2026
- Last trade
- 16 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 17 Jun 2026 | NRSN NeuroSense TherapeuticsBiotechnology | SEC FORM 4 Bought | $200K250,000 at $0.80 | filing |
| 16 Jun 2026filed 17 Jun 2026 | NRSN NeuroSense TherapeuticsBiotechnology | SEC FORM 4 Bought | $200K250,000 at $0.80 | filing |
News
NeuroSense (NASDAQ: NRSN) files TBI patent application to expand PrimeC beyond ALSNRSN · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Alon Ben-Noon; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.